A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase

被引：51

作者：

Bertolacci, Laura ^{[1
]}

Romeo, Elisa ^{[1
]}

Veronesi, Marina ^{[1
]}

Magotti, Paola ^{[1
]}

Albani, Clara ^{[1
]}

Dionisi, Mauro ^{[1
]}

Lambruschini, Chiara ^{[1
]}

Scarpelli, Rita ^{[1
]}

Cavalli, Andrea ^{[2
]}

De Vivo, Marco ^{[1
]}

Piomelli, Daniele ^{[1
,3
]}

Garau, Gianpiero ^{[1
]}

机构：

[1] Ist Italiano Tecnol, I-16163 Genoa, Italy

[2] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy

[3] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA

来源：

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 135卷 / 01期

关键词：

ALPHA-KETOHETEROCYCLE INHIBITORS; SELECTIVE FAAH INHIBITOR; PAIN INITIATION; CYCLOOXYGENASE; ENZYME; INDOMETHACIN; DISCOVERY; ENDOCANNABINOIDS; PROSTAGLANDINS; INFLAMMATION;

D O I：

10.1021/ja308733u

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase (FAAH). The X-ray structure of FAAH in complex with the NSAID carprofen, along with site-directed mutagenesis, enzyme activity assays, and NMR analysis, has revealed the molecular details of this interaction, providing information that may guide the design of dual FAAH COX inhibitors with superior analgesic efficacy.

引用

页码：22 / 25

页数：4

共 44 条

[1] Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, Kay
Johnson, Douglas S.
Mileni, Mauro
Beidler, David
Long, Jonathan Z.
McKinney, Michele K.
Weerapana, Eranthie
Sadagopan, Nalini
Liimatta, Marya
Smith, Sarah E.
Lazerwith, Scott
Stiff, Cory
Kamtekar, Satwik
Bhattacharya, Keshab
Zhang, Yanhua
Swaney, Stephen
Van Becelaere, Keri
Stevens, Raymond C.
Cravatt, Benjamin F.
[J]. CHEMISTRY & BIOLOGY, 2009, 16 (04): : 411 - 420
[2] BERGSTROM S, 1964, J BIOL CHEM, V239, P4006
[3] Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling
Bracey, MH
Hanson, MA
Masuda, KR
Stevens, RC
Cravatt, BF
[J]. SCIENCE, 2002, 298 (5599) : 1793 - 1796
[4] Breyer M. D., 2001, ANN REV PHARM TOXICO, P661
[5] Control of pain initiation by endogenous cannabinoids
Calignano, A
La Rana, G
Giuffrida, A
Piomelli, D
[J]. NATURE, 1998, 394 (6690) : 277 - 281
[6] Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Chang, Leon
Luo, Lin
Palmer, James A.
Sutton, Steven
Wilson, Sandy J.
Barbier, Ann J.
Breitenbucher, James Guy
Chaplan, Sandra R.
Webb, Michael
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (01) : 102 - 113
[7] Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Clapper, Jason R.
Moreno-Sanz, Guillermo
Russo, Roberto
Guijarro, Ana
Vacondio, Federica
Duranti, Andrea
Tontini, Andrea
Sanchini, Silvano
Sciolino, Natale R.
Spradley, Jessica M.
Hohmann, Andrea G.
Calignano, Antonio
Mor, Marco
Tarzia, Giorgio
Piomelli, Daniele
[J]. NATURE NEUROSCIENCE, 2010, 13 (10) : 1265 - 1270
[8] Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, BF
Giang, DK
Mayfield, SP
Boger, DL
Lerner, RA
Gilula, NB
[J]. NATURE, 1996, 384 (6604) : 83 - 87
[9] Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
Cravatt, BF
Demarest, K
Patricelli, MP
Bracey, MH
Giang, DK
Martin, BR
Lichtman, AH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) : 9371 - 9376
[10] Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
Cravatt, BF
Lichtman, AH
[J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (04) : 469 - 475

← 1 2 3 4 5 →